文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在转移性淋巴结中,癌症免疫治疗在人体区域淋巴结中诱导的动态 CD8 T 细胞反应被打乱。

Dynamic CD8 T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes.

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.

Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Orofacial Sciences, University of California, San Francisco, San Francisco, CA 94143, USA; Pharma Technical Cell and Gene Therapy, Genentech, Inc., South San Francisco, CA 94080, USA.

出版信息

Cell. 2023 Mar 16;186(6):1127-1143.e18. doi: 10.1016/j.cell.2023.02.021.


DOI:10.1016/j.cell.2023.02.021
PMID:36931243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10348701/
Abstract

CD8 T cell responses are critical for anti-tumor immunity. While extensively profiled in the tumor microenvironment, recent studies in mice identified responses in lymph nodes (LNs) as essential; however, the role of LNs in human cancer patients remains unknown. We examined CD8 T cells in human head and neck squamous cell carcinomas, regional LNs, and blood using mass cytometry, single-cell genomics, and multiplexed ion beam imaging. We identified progenitor exhausted CD8 T cells (Tpex) that were abundant in uninvolved LN and clonally related to terminally exhausted cells in the tumor. After anti-PD-L1 immunotherapy, Tpex in uninvolved LNs reduced in frequency but localized near dendritic cells and proliferating intermediate-exhausted CD8 T cells (Tex-int), consistent with activation and differentiation. LN responses coincided with increased circulating Tex-int. In metastatic LNs, these response hallmarks were impaired, with immunosuppressive cellular niches. Our results identify important roles for LNs in anti-tumor immune responses in humans.

摘要

CD8 T 细胞反应对于抗肿瘤免疫至关重要。虽然在肿瘤微环境中得到了广泛研究,但最近在小鼠中的研究发现淋巴结(LNs)中的反应是必不可少的;然而,LN 在人类癌症患者中的作用仍不清楚。我们使用质谱流式细胞术、单细胞基因组学和多重离子束成像技术,在人类头颈部鳞状细胞癌、局部淋巴结和血液中检查了 CD8 T 细胞。我们鉴定了在未受累的 LN 中丰富存在的祖细胞耗竭 CD8 T 细胞(Tpex),并且与肿瘤中终末耗竭细胞克隆相关。在抗 PD-L1 免疫治疗后,未受累 LNs 中的 Tpex 频率降低,但定位于树突状细胞附近并增殖中间耗竭的 CD8 T 细胞(Tex-int),与激活和分化一致。LN 反应伴随着循环 Tex-int 的增加。在转移性 LNs 中,这些反应特征受损,存在免疫抑制细胞龛。我们的研究结果确定了 LNs 在人类抗肿瘤免疫反应中的重要作用。

相似文献

[1]
Dynamic CD8 T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes.

Cell. 2023-3-16

[2]
Nanoliposomal PD-1 antagonist target tumor-draining lymph nodes to revitalize T cells and improve anti-tumor effect in hepatocellular carcinoma.

J Nanobiotechnology. 2025-7-30

[3]
Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models.

J Immunother Cancer. 2025-8-18

[4]
Single-Cell Analyses Reveal a Functionally Heterogeneous Exhausted CD8+ T-cell Subpopulation That Is Correlated with Response to Checkpoint Therapy in Melanoma.

Cancer Res. 2025-4-15

[5]
[CD8+ T Cells in Anti-Tumor Immune Response].

Gan To Kagaku Ryoho. 2025-7

[6]
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitors.

J Immunother Cancer. 2024-3-12

[7]
ANV600 is a novel PD-1 targeted IL-2Rβγ agonist that selectively expands tumor antigen-specific T cells and potentiates PD-1 checkpoint inhibitor therapy.

J Immunother Cancer. 2025-7-15

[8]
Integrated single-cell and bulk sequencing analyses with experimental validation identify the prognostic and immunological implications of CD226 in pan-cancer.

J Cancer Res Clin Oncol. 2023-11

[9]
MHC class I upregulation contributes to the therapeutic response to radiotherapy in combination with anti-PD-L1/anti-TGF-β in squamous cell carcinomas with enhanced CD8 T cell memory-driven response.

Cancer Lett. 2025-1-1

[10]
Targeting BATF2-RGS2 axis reduces T-cell exhaustion and restores anti-tumor immunity.

Mol Cancer. 2025-5-30

引用本文的文献

[1]
From trash to treasure: tumor draining lymph nodes as a multi-omics goldmine in cancer therapy.

Front Oncol. 2025-8-19

[2]
Unconventional Immunotherapies in Cancer: Opportunities and Challenges.

Pharmaceuticals (Basel). 2025-8-4

[3]
Preclinical models in the study of lymph node metastasis.

J Zhejiang Univ Sci B. 2025-6-24

[4]
Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer.

Nat Commun. 2025-8-22

[5]
Genomic and the tumor microenvironment heterogeneity in multifocal hepatocellular carcinoma.

Hepatology. 2025-9-1

[6]
GTSE1-expressed osteoblastic cells facilitate formation of pro-metastatic tumor microenvironment in osteosarcoma.

Genes Dis. 2025-3-7

[7]
Lymph nodes metastatic burden as a prognosticator for advanced non-small cell lung cancer: a real-world study.

J Thorac Dis. 2025-7-31

[8]
Prognostic Implications of T Cell Receptor Repertoire Diversity in Cervical Lymph Nodes of Oral Squamous Cell Carcinoma Patients.

Int J Mol Sci. 2025-7-23

[9]
Chimeric exosomes-derived immunomodulator restoring lymph nodes microenvironment for sensitizing TNBC immunotherapy.

Nat Commun. 2025-8-2

[10]
Cell division cycle 20 promotes tumor progression and predicts poor clinical outcome in childhood and adult adrenocortical carcinoma.

J Clin Transl Endocrinol. 2025-7-2

本文引用的文献

[1]
Robust phenotyping of highly multiplexed tissue imaging data using pixel-level clustering.

Nat Commun. 2023-8-1

[2]
MYB orchestrates T cell exhaustion and response to checkpoint inhibition.

Nature. 2022-9

[3]
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood.

J Immunother Cancer. 2022-7

[4]
Immune suppression in the tumor-draining lymph node corresponds with distant disease recurrence in patients with melanoma.

Cancer Cell. 2022-8-8

[5]
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.

Cell. 2022-8-4

[6]
'Stem-like' precursors are the fount to sustain persistent CD8 T cell responses.

Nat Immunol. 2022-6

[7]
Lymph node colonization induces tumor-immune tolerance to promote distant metastasis.

Cell. 2022-5-26

[8]
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue.

J Exp Med. 2022-6-6

[9]
A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.

Cancer Cell. 2022-5-9

[10]
Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells.

Cancer Cell. 2022-5-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索